Another feather in the cap........

[kmall]

Biotech Breakthrough Awards 2023.......

https://biotechbreakthroughawards.com/2023-winners/

When does all of this recognition finally get recognized ??? -Kmall

[Ryan]

Such valid conjecture there.

From the data, I would be absolutely stunned/shocked absolutely flummoxed, choose your word… if Imetelstat is not approved for marketing authorization by the FDA…
— But from the vibes and the Geron share price, I wouldn’t be surprised in the least <— go figure.

[Gwikley]

Imet inducing ferroptosis is a pretty big deal. Not sure what kind of news it will take to move this stock. This certainly seems to be one.

[kmall]

Ryan and Gwik - Indeed ferroptosis is a HUGE deal, and abstract 201 from last year's ASH stood out for that very reason. As both Bp and Ryan have pointed out in previous threads, highly unlikely that we see a late breaking abstract connected to recent findings in Australia with Drs Lane and Bruedigam......never say never, but I wouldn't be holding my breath.

And Gwik, to your point on the Hedge funds playing both sides of the coin with regards to the SP - absolutely. That's what these guys do. Most are here for nothing more than to make $$....GERN is simply a vehicle for them, in either direction. Some of the other venture capital is here for the medical/scientific investment potential and have a much longer investment horizon. While management prefers a low SP for other reasons, it is refreshing to have the addition of a former US Attorney to the legal department. I doubt we see any frivolous lawsuits in the very near future. -Kmall

[biopearl123]

A little lite background reading:

https://www.nature.com/articles/s41419-020-2298-2

Kmall, Good call on the high powered corporate attorney hires by the way.